Lars Gösta Jonsson
Keine laufenden Positionen mehr
Profil
Lars Gösta Jonsson formerly worked at Mando AB, as Director, KDev Exploratory AB, as Director, BioArctic AB, as Director & Professor, Synosia Therapeutics, Inc., as Director, AstraZeneca PLC, as Vice President-Global Discovery Affairs from 2001 to 2005, BioPhausia AB, as Principal from 1999 to 2003, Collegium Pharmaceutical, Inc., as Member, Synosia Therapeutics AG, as Member-Management Board, Karolinska Institutet, as Professor from 1967 to 1986, Astra Arcus AB, as President from 1989 to 1999, and Pharmacia Ophthalmics AB, as Vice President from 1986 to 1989.
Ehemalige bekannte Positionen von Lars Gösta Jonsson
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2005 |
BioPhausia AB
 BioPhausia AB Medical DistributorsDistribution Services BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 01.01.2003 |
| Astra Arcus AB | Präsident | 01.01.1999 |
| Pharmacia Ophthalmics AB | Corporate Officer/Principal | 01.01.1989 |
| Karolinska Institutet | Corporate Officer/Principal | 01.01.1986 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BIOARCTIC AB | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Commercial Services |
| Pharmacia Ophthalmics AB | |
| Astra Arcus AB | |
BioPhausia AB
BioPhausia AB Medical DistributorsDistribution Services BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden. | Distribution Services |
Synosia Therapeutics AG
 Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Synosia Therapeutics develops and intends to commercialize innovative products for unmet medical needs in psychiatry and neurology. The firm is working to extend the reach of marketed and clinical-stage compounds, acquired through strategic partnerships with Novartis, Roche and Syngenta, into new indications with significant potential. Founded in December 2005 and headquartered in Switzerland, Synosia is managed by a highly experienced management team with some 200 years of drug development experience. The company is backed by $62 million in funding from high-quality investors and has a rich portfolio of compounds. | Health Technology |
Synosia Therapeutics, Inc.
 Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Synosia Therapeutics, Inc. used to develop products for unmet medical needs in psychiatry and neurology. The company was founded in December 2005 and was headquartered in San Francisco, CA. | Health Technology |
Mando AB
 Mando AB Medical/Nursing ServicesHealth Services Mando AB engages in the provision of health care services. It offers treatment for anorexia nervosa and bulimia nervosa as well as other eating disorders using Mandometer Method. The company was founded in 2000 and is headquartered in Huddinge, Sweden. | Health Services |
